+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vein Illuminator Market Size, Share & Trends Analysis Report by Technology, by Application, by End Use, by Region, and Segment Forecasts, 2020-2027

  • PDF Icon

    Report

  • 86 Pages
  • May 2020
  • Region: Global
  • Grand View Research
  • ID: 5028718
Vein Illuminator Market Growth & Trends

The global vein illuminator market size is expected to reach USD 793.8 million by 2027, registering revenue based CAGR of 30.6% over the forecast period. Growing demand for easy visualization of inaccessible veins in neonates, elderly, dark skinned, and obese patients is expected to aid the market growth. Moreover, growing need for intravenous drugs for the treatment of various disorders is anticipated to further propel the product demand.

As per the American Civil Liberties Union, 350,000 people in the U.S. regularly use injectable drugs. The process requires proper knowledge regarding IV drugs in order to avoid infections that are caused due to injection drug use. Therefore, growing adoption of IV drugs for various purposes is expected to boost the adoption of vein illuminators for avoiding infections and enhancing proper treatment.

Growing demand for painless insertion in drawing blood or intravenous access is also expected to drive the market growth. These devices are mainly advantageous for the application in children and adults, as it reduces the risks of multiple needle pricks done to infants and old age patients. Illumination technology eases the job of clinicians by creating a road map of the main vein.

Rising prevalence of chronic diseases worldwide is increasing the demand for diagnosis and treatment, which in turn is expected to drive the market growth. According to recent studies, it is estimated that around 500 million venipuncture procedures are performed every year. Usage of vein illuminator increases the success rate of venipuncture and hence enhances the diagnosis and treatment.

Vein Illuminator Market Report Highlights
  • Infrared technology held the largest revenue share in 2019 and is expected to grow at the fastest rate during the forecast period mainly due to its ability to illuminate veins located deep inside the tissue for proper intravenous access and blood draw
  • Transillumination technology is also expected to experience a significant growth during the forecast period because it uses LED lights, which enhances the structure of the vein
  • The intravenous access segment held the largest revenue share in 2019 and is expected to register the fastest growth rate largely due to increasing usage of intravenous drugs for treatment of various chronic diseases
  • The usage of vein illuminators is also increasing mainly because of growing demand for diagnosing chronic diseases and for avoiding the after effects or infections of multiple needle pricks
  • The hospitals segment held the largest revenue share and is expected to experience the fastest growth rate during the forecast period increasing adoption in hospitals for streamlining the IV procedures with comfort
  • North America dominated the vein illuminator market with the largest revenue share in 2019 owing to the presence of major market players and increasing product launches in the region
  • Asia Pacific is expected to grow at the fastest growth rate during the forecast period mainly due to growing healthcare expenditure in the region and growing strategic alliances between the global players for distribution in the region


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal Database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Vein Illuminator Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Efforts to reduce pain by use of multiple needle sticks
3.4.1.2. Rise in phlebotomy/venipuncture procedures
3.4.1.3. Growing prevalence of venous leg ulcer
3.4.1.4. Growing strategic alliances for vein illuminators
3.4.2. Market restraint analysis
3.4.2.1. Low penetration of vein illuminator in developing and under-developed countries
3.4.3. Industry challenges
3.5. Vein Illuminator Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Technology Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Transillumination
4.1.2. Infrared
4.1.3. Ultrasound
4.2. Technology Market Share, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Vein Illuminator Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Transillumination
4.5.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
4.5.2. Infrared
4.5.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
4.5.3. Ultrasound
4.5.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
Chapter 5. Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Intravenous Access
5.1.2. Blood Draw
5.1.3. Others
5.2. Application Market Share, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Vein Illuminator Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Intravenous access
5.5.1.1. Market estimates and forecast, 2016 - 2027 (Revenue in USD Million)
5.5.2. Blood draw
5.5.2.1. Market estimates and forecast, 2016 - 2027 (Revenue in USD Million)
5.5.3. Others
5.5.3.1. Market estimates and forecast, 2016 - 2027 (Revenue in USD Million)
Chapter 6. End Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Blood Donation Camps
6.1.3. Academic Institutions
6.1.4. Others
6.2. End-Use Market Share, 2019 & 2027
6.3. Segment Dashboard
6.4. Global Vein Illuminator Market by End-Use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
6.5.1. Hospitals
6.5.1.1. Market estimates and forecast, 2016 - 2027 (Revenue in USD Million)
6.5.2. Blood donation camps
6.5.2.1. Market estimates and forecast, 2016 - 2027 (Revenue in USD Million)
6.5.3. Academic Institutions
6.5.3.1. Market estimates and forecast, 2016 - 2027 (Revenue in USD Million)
6.5.4. Others
6.5.4.1. Market estimates and forecast, 2016 - 2027 (Revenue in USD Million)
Chapter 7. Vein Illuminator Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2019 & 2027
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2019
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.8. Europe
7.8.1. U.K.
7.8.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.8.6. Russia
7.8.6.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.8.7. Netherlands
7.8.7.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.8.8. Switzerland
7.8.8.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.8.9. Turkey
7.8.9.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.8.10. Poland
7.8.10.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.9.2. China
7.9.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.9.4. Thailand
7.9.4.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.9.5. South Korea
7.9.5.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.9.6. Indonesia
7.9.6.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.9.7. Taiwan
7.9.7.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.9.8. Hong Kong
7.9.8.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.9.9. Philippines
7.9.9.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.9.10. Malaysia
7.9.10.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.10.4. Colombia
7.10.4.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.10.5. Chile
7.10.5.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
7.11.5. Qatar
7.11.5.1. Market estimates and forecast, 2016 - 2027 (Revenue, USD Million, Volume, Units)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Leaders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2019
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company Market Share/Ranking, by region
8.4.3. Competitive Dashboard Analysis
8.4.3.1. Market Differentiators
8.4.3.2. Synergy Analysis: Major Deals and Strategic Alliances
8.5. Private Companies
8.5.1. List of key emerging companies/technology disruptors/innovators
8.5.2. Funding Outlook
8.5.3. Regional Network Map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.6. Supplier Ranking
8.7. Key company profiled
8.7.1. Accuvein, Inc.
8.7.1.1. Company overview
8.7.1.2. Financial performance
8.7.1.3. Product benchmarking
8.7.1.4. Strategic initiatives
8.7.2. Christie Medical Holdings, Inc.
8.7.2.1. Company overview
8.7.2.2. Financial performance
8.7.2.3. Product benchmarking
8.7.2.4. Strategic initiatives
8.7.3. InfraRed Imaging Systems, Inc.
8.7.3.1. Company overview
8.7.3.2. Financial performance
8.7.3.3. Product benchmarking
8.7.3.4. Strategic initiatives
8.7.4. Venoscope
8.7.4.1. Company overview
8.7.4.2. Financial performance
8.7.4.3. Product benchmarking
8.7.4.4. Strategic initiatives
8.7.5. TransLite LLC
8.7.5.1. Company overview
8.7.5.2. Financial performance
8.7.5.3. Product benchmarking
8.7.5.4. Strategic initiatives
8.7.6. VueTek Scientific, LLC.
8.7.6.1. Company overview
8.7.6.2. Financial performance
8.7.6.3. Product benchmarking
8.7.6.4. Strategic initiatives
8.7.7. ZD Medical, Inc.
8.7.7.1. Company overview
8.7.7.2. Financial performance
8.7.7.3. Product benchmarking
8.7.7.4. Strategic initiatives
8.7.8. Cambridge Medical (Asia) Private Limited
8.7.8.1. Company overview
8.7.8.2. Financial performance
8.7.8.3. Product benchmarking
8.7.8.4. Strategic initiatives
8.7.9. BK Ultrasound
8.7.9.1. Company overview
8.7.9.2. Financial performance
8.7.9.3. Product benchmarking
8.7.9.4. Strategic initiatives
8.7.10. Near Infrared Imaging, Inc.
8.7.10.1. Company overview
8.7.10.2. Financial performance
8.7.10.3. Product benchmarking
8.7.10.4. Strategic initiatives

Companies Mentioned

  • Accuvein, Inc.
  • Christie Medical Holdings, Inc.
  • InfraRed Imaging Systems, Inc.
  • Venoscope
  • TransLite LLC
  • VueTek Scientific, LLC.
  • ZD Medical, Inc.
  • Cambridge Medical (Asia) Private Limited
  • BK Ultrasound
  • Near Infrared Imaging, Inc.

Methodology

Loading
LOADING...